{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:38:55Z","timestamp":1785523135918,"version":"3.56.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T00:00:00Z","timestamp":1572393600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,30]],"date-time":"2019-10-30T00:00:00Z","timestamp":1572393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100001845","name":"Scleroderma Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001845","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["K23AR067889"],"award-info":[{"award-number":["K23AR067889"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["K24AR063120"],"award-info":[{"award-number":["K24AR063120"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01AR073208"],"award-info":[{"award-number":["R01AR073208"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["K23AR075112"],"award-info":[{"award-number":["K23AR075112"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012462","name":"Office of Academic Affiliations, Department of Veterans Affairs","doi-asserted-by":"publisher","award":["CX001183"],"award-info":[{"award-number":["CX001183"]}],"id":[{"id":"10.13039\/100012462","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009224","name":"Advanced Research Projects Agency","doi-asserted-by":"publisher","award":["W81XWH-16-1-0296"],"award-info":[{"award-number":["W81XWH-16-1-0296"]}],"id":[{"id":"10.13039\/100009224","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s10067-019-04792-y","type":"journal-article","created":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T09:03:43Z","timestamp":1574154223000},"page":"93-102","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Collaborative National Quality and Efficacy Registry (CONQUER) for Scleroderma: outcomes from a multicenter US-based systemic sclerosis registry"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5882-4884","authenticated-orcid":false,"given":"Victoria K.","family":"Shanmugam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy M.","family":"Frech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia D.","family":"Steen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura K.","family":"Hummers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ami A.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elana J.","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica K.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia V.","family":"Castelino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorinda","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faye N.","family":"Hant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Startup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"VanBuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke B.","family":"Evnin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shervin","family":"Assassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,30]]},"reference":[{"issue":"4","key":"4792_CR1","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.semarthrit.2007.05.003","volume":"37","author":"H Chifflot","year":"2008","unstructured":"Chifflot H, Fautrel B, Sordet C, Chatelus E, Sibilia J (2008) Incidence and prevalence of systemic sclerosis: a systematic literature review. Semin Arthritis Rheum 37(4):223\u2013235","journal-title":"Semin Arthritis Rheum"},{"issue":"6","key":"4792_CR2","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1097\/BOR.0b013e3282e6f495","volume":"19","author":"M Trojanowska","year":"2007","unstructured":"Trojanowska M, Varga J (2007) Molecular pathways as novel therapeutic targets in systemic sclerosis. Curr Opin Rheumatol 19(6):568\u2013573","journal-title":"Curr Opin Rheumatol"},{"issue":"3","key":"4792_CR3","doi-asserted-by":"publisher","first-page":"137","DOI":"10.5301\/jsrd.5000249","volume":"2","author":"J Varga","year":"2017","unstructured":"Varga J, Trojanowska M, Kuwana M (2017) Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities. J Scleroderma Relat Disord 2(3):137\u2013152","journal-title":"J Scleroderma Relat Disord"},{"issue":"1","key":"4792_CR4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13075-019-1822-1","volume":"21","author":"J Blagojevic","year":"2019","unstructured":"Blagojevic J, Bellando-Randone S, Abignano G, Avouac J, Cometi L, Czirj\u00e1k L, Denton CP, Distler O, Frerix M, Guiducci S, Huscher D, Jaeger VK, L\u00f3r\u00e1nd V, Maurer B, Nihtyanova S, Riemekasten G, Siegert E, Tarner IH, Vettori S, Walker UA, Allanore Y, M\u00fcller-Ladner U, del Galdo F, Matucci-Cerinic M, EUSTAR co-workers (2019) Classification, categorization and essential items for digital ulcer evaluation in systemic sclerosis: a DeSScipher\/European Scleroderma Trials and Research group (EUSTAR) survey. Arthritis Res Ther 21(1):35","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"4792_CR5","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1136\/annrheumdis-2018-213455","volume":"78","author":"Wanlong Wu","year":"2019","unstructured":"Wu W et al (2019) Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort. Ann Rheum Dis 78(5):648\u2013656. \nhttps:\/\/doi.org\/10.1136\/annrheumdis-2018-213455","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"1","key":"4792_CR6","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/1756-185X.13433","volume":"22","author":"JW Park","year":"2019","unstructured":"Park JW, Ahn GY, Kim JW, Park ES, Kang JH, Chang SH, Choi IA, Yoo SJ, Park JK, Shin K, Park YB, Jun JB, Czirj\u00e1k L, Allanore Y, Matucci-Cerinic M, Lee EB (2019) Impact of EUSTAR standardized training on accuracy of modified Rodnan skin score in patients with systemic sclerosis. Int J Rheum Dis 22(1):96\u2013102","journal-title":"Int J Rheum Dis"},{"issue":"4","key":"4792_CR7","first-page":"68","volume":"36 Suppl 113","author":"PE Carreira","year":"2018","unstructured":"Carreira PE et al (2018) Gender differences in early systemic sclerosis patients: a report from the EULAR scleroderma trials and research group (EUSTAR) database. Clin Exp Rheumatol 36 Suppl 113(4):68\u201375","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"4792_CR8","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/rheumatology\/kex182","volume":"57","author":"VK Jaeger","year":"2018","unstructured":"Jaeger VK, Distler O, Maurer B, Czirj\u00e1k L, L\u00f3r\u00e1nd V, Valentini G, Vettori S, del Galdo F, Abignano G, Denton C, Nihtyanova S, Allanore Y, Avouac J, Riemekasten G, Siegert E, Huscher D, Matucci-Cerinic M, Guiducci S, Frerix M, Tarner IH, Garay Toth B, Fankhauser B, Umbricht J, Zakharova A, Mihai C, Cozzi F, Yavuz S, Hunzelmann N, Rednic S, Vacca A, Schmeiser T, Riccieri V, Garc\u00eda de la Pe\u00f1a Lefebvre P, Gabrielli A, Krummel-Lorenz B, Martinovic D, Ancuta C, Smith V, M\u00fcller-Ladner U, Walker UA (2018) Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group. Rheumatology (Oxford) 57(3):441\u2013450","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"4792_CR9","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s10067-016-3501-9","volume":"36","author":"B Levis","year":"2017","unstructured":"Levis B, Kwakkenbos L, Hudson M, Baron M, Thombs BD, and the Canadian Scleroderma Research Group (2017) The association of sociodemographic and objectively-assessed disease variables with fatigue in systemic sclerosis: an analysis of 785 Canadian Scleroderma Research Group Registry patients. Clin Rheumatol 36(2):373\u2013379","journal-title":"Clin Rheumatol"},{"issue":"8","key":"4792_CR10","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1002\/acr.22802","volume":"68","author":"B Levis","year":"2016","unstructured":"Levis B, Rice DB, Kwakkenbos L, Steele RJ, Hagedoorn M, Hudson M, Baron M, Thombs BD, Canadian Scleroderma Research Group (2016) Using marital status and continuous marital satisfaction ratings to predict depressive symptoms in married and unmarried women with systemic sclerosis: a Canadian scleroderma research group study. Arthritis Care Res (Hoboken) 68(8):1143\u20131149","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"4","key":"4792_CR11","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1002\/acr.22451","volume":"67","author":"H Alhajeri","year":"2015","unstructured":"Alhajeri H, Hudson M, Fritzler M, Pope J, Tatibouet S, Markland J, Robinson D, Jones N, Khalidi N, Docherty P, Kaminska E, Masetto A, Sutton E, Mathieu JP, Ligier S, Grodzicky T, LeClercq S, Thorne C, Gyger G, Smith D, Fortin PR, Larch\u00e9 M, Baron M (2015) 2013 American College of Rheumatology\/European League against rheumatism classification criteria for systemic sclerosis outperform the 1980 criteria: data from the Canadian Scleroderma Research Group. Arthritis Care Res (Hoboken) 67(4):582\u2013587","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"4792_CR12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.5694\/mja16.01135","volume":"206","author":"M Nikpour","year":"2017","unstructured":"Nikpour M, Proudman S, Morrisroe K, Sahhar JM, Stevens W (2017) The Australian Scleroderma Interest Group and database: 10 years of screening to save lives. Med J Aust 206(5):229","journal-title":"Med J Aust"},{"issue":"1","key":"4792_CR13","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3899\/jrheum.150382","volume":"43","author":"P Moinzadeh","year":"2016","unstructured":"Moinzadeh P, Riemekasten G, Siegert E, Fierlbeck G, Henes J, Blank N, Melchers I, Mueller-Ladner U, Frerix M, Kreuter A, Tigges C, Lahner N, Susok L, Guenther C, Zeidler G, Pfeiffer C, Worm M, Karrer S, Aberer E, Bretterklieber A, Genth E, Simon JC, Distler JH, Hein R, Schneider M, Seitz CS, Herink C, Steinbrink K, S\u00e1rdy M, Varga R, Mensing H, Mensing C, Lehmann P, Neeck G, Fiehn C, Weber M, Goebeler M, Burkhardt H, Buslau M, Ahmadi-Simab K, Himsel A, Juche A, Koetter I, Kuhn A, Sticherling M, Hellmich M, Kuhr K, Krieg T, Ehrchen J, Sunderkoetter C, Hunzelmann N, German Network for Systemic Scleroderma (2016) Vasoactive therapy in systemic sclerosis: real-life therapeutic practice in more than 3000 patients. J Rheumatol 43(1):66\u201374","journal-title":"J Rheumatol"},{"issue":"4","key":"4792_CR14","first-page":"53","volume":"36 Suppl 113","author":"K Morrisroe","year":"2018","unstructured":"Morrisroe K, Hudson M, Baron M, de Vries-Bouwstra J, Carreira PE, Wuttge DM, Wang M, Frech TM, Stevens W, Proudman SM, Nikpour M, International Systemic Sclerosis Inception Cohort (INSYNC) collaboration (2018) Determinants of health-related quality of life in a multinational systemic sclerosis inception cohort. Clin Exp Rheumatol 36 Suppl 113(4):53\u201360","journal-title":"Clin Exp Rheumatol"},{"issue":"2 Suppl 76","key":"4792_CR15","first-page":"166","volume":"31","author":"TM Frech","year":"2013","unstructured":"Frech TM, Shanmugam VK, Shah AA, Assassi S, Gordon JK, Hant FN, Hinchcliff ME, Steen V, Khanna D, Kayser C, Domsic RT (2013) Treatment of early diffuse systemic sclerosis skin disease. Clin Exp Rheumatol 31(2 Suppl 76):166\u2013171","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"4792_CR16","doi-asserted-by":"publisher","first-page":"e003563","DOI":"10.1136\/bmjopen-2013-003563","volume":"3","author":"Linda Kwakkenbos","year":"2013","unstructured":"Kwakkenbos L et al (2013) The Scleroderma Patient-centered Intervention Network (SPIN) Cohort: protocol for a cohort multiple randomised controlled trial (cmRCT) design to support trials of psychosocial and rehabilitation interventions in a rare disease context. BMJ Open 3(8). \nhttps:\/\/doi.org\/10.1136\/bmjopen-2013-003563","journal-title":"BMJ Open"},{"key":"4792_CR17","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/978-3-319-67144-4_8","volume":"1031","author":"Y Kodra","year":"2017","unstructured":"Kodra Y, Posada de la Paz M, Coi A, Santoro M, Bianchi F, Ahmed F, Rubinstein YR, Weinbach J, Taruscio D (2017) Data quality in rare diseases registries. Adv Exp Med Biol 1031:149\u2013164","journal-title":"Adv Exp Med Biol"},{"issue":"8","key":"4792_CR18","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.3390\/ijerph15081644","volume":"15","author":"Yllka Kodra","year":"2018","unstructured":"Kodra Y et al (2018) Recommendations for improving the quality of rare disease registries. Int J Environ Res Public Health 15(8). \nhttps:\/\/doi.org\/10.3390\/ijerph15081644","journal-title":"International Journal of Environmental Research and Public Health"},{"issue":"2","key":"4792_CR19","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG (2009) Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42(2):377\u2013381","journal-title":"J Biomed Inform"},{"key":"4792_CR20","doi-asserted-by":"publisher","first-page":"160018","DOI":"10.1038\/sdata.2016.18","volume":"3","author":"MD Wilkinson","year":"2016","unstructured":"Wilkinson MD et al (2016) The FAIR guiding principles for scientific data management and stewardship. Sci Data 3:160018","journal-title":"Sci Data"},{"issue":"3","key":"4792_CR21","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1007\/s12016-017-8636-1","volume":"55","author":"M Cossu","year":"2018","unstructured":"Cossu M, Beretta L, Mosterman P, de Hair MJH, Radstake TRDJ (2018) Unmet needs in systemic sclerosis understanding and treatment: the knowledge gaps from a scientist\u2019s, clinician\u2019s, and patient\u2019s perspective. Clin Rev Allergy Immunol 55(3):312\u2013331","journal-title":"Clin Rev Allergy Immunol"},{"issue":"5","key":"4792_CR22","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.semarthrit.2016.10.002","volume":"46","author":"F Ingegnoli","year":"2017","unstructured":"Ingegnoli F, Carmona L, Castrejon I (2017) Systematic review of systemic sclerosis-specific instruments for the EULAR Outcome Measures Library: an evolutional database model of validated patient-reported outcomes. Semin Arthritis Rheum 46(5):609\u2013614","journal-title":"Semin Arthritis Rheum"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04792-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10067-019-04792-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-019-04792-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T00:52:20Z","timestamp":1603932740000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10067-019-04792-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,30]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["4792"],"URL":"https:\/\/doi.org\/10.1007\/s10067-019-04792-y","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,30]]},"assertion":[{"value":"17 August 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was conducted in compliance with the ethical rules for human subject research as outlined in the 1975 Declaration of Helsinki. The CONQUER scleroderma registry is IRB approved at each of the individual institutions. All subjects gave written informed consent for collection of specimens and data.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"VKS receives research funding from Abbvie Pharmaceuticals.TMF has no conflict of interest to disclose.VDS has received research funding from CSL Behring, and consultancy fees from Bayer, Boehringer Ingelheim, CSL Behring, Cytori and Genetech\/Roche. She is on the Data Safety and Monitoring Board for Corbus and Galapagos.LKH receives research funding from Boehringer-Ingelheim, Eicos, Glaxo Smith Klein, Cumberland Pharmaceuticals and Corbus Pharmaceuticals and is on the medical advisory board for Boehringer-Ingelheim and CSL Behring.AAS serves on a data safety monitoring board for Sanofi.EJB receives grant support from Pfizer.DK has received research funding from Bayer, BMS, Horizon and Pfizer, as well as consultancy fees from Acceleron, Actelion, Bayer, BMS, Boehringer Ingelheim, Celgene, Corbus, CSL Behring, Cytori, Genetech\/Roche and Sanofi. DK owns stock in Eicos Sciences, Inc., and is employed by the University of Michigan and CiviBioPharma, Inc.JKG has research funding from Eicos, Cumberland Pharmaceuticals and Corbus Pharmaceuticals.FVC has received consultancy fees from Boehringer-Ingelheim and Genentech.LC receives research funding from United Therapeutics, serves on the Data Safety Monitoring Board for Reata, and has received consultancy fees from Bristol-Myers Squibb, Boehringer-Ingelheim, Eicos and Mitsubishi Tanabe.FNH has no conflict of interest to disclose.ES has no conflict of interest to disclose.JMV has no conflict of interest to disclose.LBE is Chairman of the Board of the Scleroderma Research Foundation (a volunteer, uncompensated position) and is co-founder and co-owner of MPM Capital, which has invested in various biopharmaceutical companies; LBE represents MPM Capital on the Board of Directors for each of Blade Therapeutics, Tizona Therapeutics, Oncorus, Frontier Medicines, Werewolf Therapeutics, TwentyEight-Seven Therapeutics and Amphivena Therapeutics. LBE owns stock directly in Eicos Sciences, and affiliate of CiVi Biopharma.SA received grant support from Bayer, Boehringer-Ingelheim, Biogen and Momenta, consultancy fees from Boehringer-Ingelheim, and speaking fees from Integrity Continuing Education and Medscape.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}